Fundz

Seabelife Secures €1.2M To Develop Drug Candidates Intended To Block Cell Necrosis

PRIVATESep 27, 2023

Amount Raised

€1.2 Million

Round Type

Seed

BiotechnologyHealth Careresearch

Investors

Professor KinetBadgeWe LikeAngels SantéBreizh AngelsI X Life Fund

Description

French biotech firm SeaBeLife has raised €1.2 million in additional seed funding to fund the further development of its drug candidates for acute liver disease and eye disorders as well as allow it to expand its team. The company intends to hire ‘several high-level specialists’ as it looks to launch a trial in severe hepatitis next year

Quick answer

SeaBeLife raised €1.2 Million in a Seed round, dated September 27, 2023. Investors: Professor Kinet, Badge, We Like, Angels Santé, Breizh Angels and I X Life Fund.

How much did SeaBeLife raise?
SeaBeLife raised €1.2 Million in a Seed round on September 27, 2023.
Who invested in SeaBeLife?
Professor Kinet, Badge, We Like, Angels Santé, Breizh Angels and I X Life Fund are named as investors in this round.
What does SeaBeLife do?
SeaBeLife is developing first-in-class small molecules designed to inhibit both necroptosis and ferroptosis, two regulated cell death pathways implicated in tissue damage associated with rare, acute and chronic diseases.
Where is SeaBeLife based and how big is it?
Fundz records about 10 employees.
Who are the decision-makers at SeaBeLife?
Fundz holds 1 contact at SeaBeLife. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in research and Biotechnology around the same time

Companies in the same sectors as SeaBeLife that raised within 45 days of this round, from Fundz verified event records.

  • Aptose Biosciences raised $3M (Seed) on September 6, 2023.
  • QuantHealth raised $15M (Series A) on August 31, 2023.
  • Epigenic Therapeutics raised $32M (Series A) on August 30, 2023.
  • Vivalink raised an undisclosed amount (Funding Round) on November 9, 2023.
  • Nūmi (ex-MUMilk) raised $3.2M (Seed) on November 9, 2023.
  • SURGLASSES raised $6.5M (Funding Round) on November 9, 2023.

Who to call at SeaBeLife, and when

A new round usually means SeaBeLife is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day SeaBeLife raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at SeaBeLife, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at SeaBeLife. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

SeaBeLife

Location

Place Georges Teissier

About

SeaBeLife is developing first-in-class small molecules designed to inhibit both necroptosis and ferroptosis, two regulated cell death pathways implicated in tissue damage associated with rare, acute and chronic diseases. This dual-target approach is currently not available on the market and is seen as a potentially transformative strategy in organ protection.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment SeaBeLife raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for SeaBeLife's next move

See what Strategic adds

SeaBeLife raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.